Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells

The PDL1-PD1 immune checkpoint inhibits T cell activation, and its blockade is effective in a subset of patients. Studies are investigating how checkpoints are hijacked by cancer cells and why most patients remain resistant to immunotherapy. Epithelial mesenchymal transition (EMT), which drives tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yan, Lu, Xiaoqin, Chen, Yao, Rendon, Beatriz, Mitchell, Robert A., Cuatrecasas, Miriam, Cortés, Marlies, Postigo, Antonio, Liu, Yongqing, Dean, Douglas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139582/
https://www.ncbi.nlm.nih.gov/pubmed/34020945
http://dx.doi.org/10.1126/sciadv.abd7455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139582/
https://www.ncbi.nlm.nih.gov/pubmed/34020945
http://dx.doi.org/10.1126/sciadv.abd7455

Ejemplares similares